# LianBio: filings

LIANY · OTC · CIK 1831283 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/liany.md) · [Financials](/companies/liany/financials.md) · [Filings](/companies/liany/filings.md) · [Insiders](/companies/liany/insiders.md)

## Reports and events: 49 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 42, 8-K 29, 3 14, CORRESP 9, UPLOAD 9, 10-Q 7, EFFECT 4, S-1/A 4, SC 13G 4, DEFA14A 3, DRS/A 3, DRSLTR 3, S-3/A 3, S-8 3, S-8 POS 3, 10-K 2, 144 2, D 2, DEF 14A 2, SC 13D 2, SC 13G/A 2, SEC STAFF LETTER 2, 10-Q/A 1, 15-12G 1, 25 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, DEFR14A 1, DRS 1, F-6 1, F-6/A 1, F-6 POS 1, POS AM 1, S-1 1, S-3 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2024-02-29 | 19:45 ET | [SC 13D/A](/filings/0001193125-24-053902.md) | Ownership report, active investor, amended | 0001193125-24-053902 |
| 2024-02-13 | 07:04 ET | [8-K](/filings/0001831283-24-000004.md) | 2.05 Exit or disposal costs; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001831283-24-000004 |
| 2023-12-26 | 16:07 ET | [8-K](/filings/0001831283-23-000145.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001831283-23-000145 |
| 2023-12-20 | 08:05 ET | [8-K](/filings/0001831283-23-000141.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-23-000141 |
| 2023-12-19 | 16:26 ET | [8-K](/filings/0001831283-23-000137.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-23-000137 |
| 2023-12-06 | 16:23 ET | [8-K](/filings/0001831283-23-000133.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-23-000133 |
| 2023-12-01 | 16:16 ET | [8-K](/filings/0001831283-23-000129.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001831283-23-000129 |
| 2023-11-30 | 17:08 ET | [SC 13D](/filings/0001214659-23-015813.md) | Ownership report, active investor | 0001214659-23-015813 |
| 2023-11-13 | 16:28 ET | [10-Q](/filings/0001831283-23-000126.md) | Quarterly report, period 2023-09-30 | 0001831283-23-000126 |
| 2023-11-13 | 16:17 ET | [8-K](/filings/0001831283-23-000124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831283-23-000124 |
| 2023-10-30 | 16:16 ET | [8-K](/filings/0001831283-23-000117.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-23-000117 |
| 2023-08-14 | 16:21 ET | [10-Q](/filings/0001831283-23-000110.md) | Quarterly report, period 2023-06-30 | 0001831283-23-000110 |
| 2023-08-14 | 16:11 ET | [8-K](/filings/0001831283-23-000107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831283-23-000107 |
| 2023-06-23 | 16:17 ET | [8-K](/filings/0001831283-23-000092.md) | 5.07 Shareholder vote results | 0001831283-23-000092 |
| 2023-05-11 | 16:33 ET | [10-Q](/filings/0001831283-23-000081.md) | Quarterly report, period 2023-03-31 | 0001831283-23-000081 |
| 2023-05-11 | 16:23 ET | [8-K](/filings/0001831283-23-000079.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831283-23-000079 |
| 2023-05-01 | 07:28 ET | [8-K](/filings/0001831283-23-000073.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-23-000073 |
| 2023-04-26 | 08:07 ET | [8-K](/filings/0001831283-23-000071.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001831283-23-000071 |
| 2023-04-21 | 16:13 ET | [8-K](/filings/0001831283-23-000067.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001831283-23-000067 |
| 2023-04-19 | 16:17 ET | [DEF 14A](/filings/0001831283-23-000061.md) | Proxy statement, period 2023-06-21 | 0001831283-23-000061 |
| 2023-03-28 | 17:23 ET | [10-K](/filings/0001831283-23-000041.md) | Annual report, period 2022-12-31 | 0001831283-23-000041 |
| 2023-03-27 | 08:40 ET | [8-K](/filings/0001831283-23-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831283-23-000034 |
| 2023-03-17 | 16:05 ET | [8-K](/filings/0001831283-23-000025.md) | 5.02 Departure or appointment of officers or directors | 0001831283-23-000025 |
| 2022-12-19 | 07:04 ET | [8-K](/filings/0001831283-22-000082.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-22-000082 |
| 2022-12-13 | 17:03 ET | [8-K](/filings/0001831283-22-000079.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001831283-22-000079 |
| 2022-11-10 | 16:33 ET | [10-Q](/filings/0001831283-22-000075.md) | Quarterly report, period 2022-09-30 | 0001831283-22-000075 |
| 2022-11-10 | 16:16 ET | [8-K](/filings/0001831283-22-000071.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-22-000071 |
| 2022-10-12 | 16:20 ET | [8-K](/filings/0001831283-22-000064.md) | 8.01 Other events | 0001831283-22-000064 |
| 2022-08-11 | 16:44 ET | [10-Q](/filings/0001831283-22-000061.md) | Quarterly report, period 2022-06-30 | 0001831283-22-000061 |
| 2022-08-11 | 16:30 ET | [8-K](/filings/0001831283-22-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831283-22-000059 |
| 2022-06-10 | 16:14 ET | [8-K](/filings/0001831283-22-000044.md) | 5.07 Shareholder vote results | 0001831283-22-000044 |
| 2022-05-12 | 16:39 ET | [10-Q](/filings/0001831283-22-000042.md) | Quarterly report, period 2022-03-31 | 0001831283-22-000042 |
| 2022-05-12 | 09:15 ET | [8-K](/filings/0001831283-22-000037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-22-000037 |
| 2022-04-27 | 08:17 ET | [DEF 14A](/filings/0001831283-22-000025.md) | Proxy statement, period 2022-06-08 | 0001831283-22-000025 |
| 2022-04-08 | 16:10 ET | [8-K](/filings/0001831283-22-000021.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001831283-22-000021 |
| 2022-03-31 | 08:55 ET | [10-K](/filings/0001831283-22-000014.md) | Annual report, period 2021-12-31 | 0001831283-22-000014 |
| 2022-03-30 | 16:55 ET | [8-K](/filings/0001831283-22-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831283-22-000012 |
| 2022-03-02 | 16:42 ET | [8-K](/filings/0001831283-22-000005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001831283-22-000005 |
| 2022-01-10 | 16:06 ET | [10-Q/A](/filings/0001193125-22-005640.md) | Quarterly report, amended, period 2021-09-30 | 0001193125-22-005640 |
| 2021-12-09 | 17:24 ET | [10-Q](/filings/0001193125-21-352813.md) | Quarterly report, period 2021-09-30 | 0001193125-21-352813 |
| 2021-12-09 | 16:59 ET | [8-K](/filings/0001193125-21-352750.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-352750 |
| 2021-11-15 | 17:03 ET | [SC 13D](/filings/0001193125-21-330078.md) | Ownership report, active investor | 0001193125-21-330078 |
| 2021-11-10 | 16:30 ET | [8-K](/filings/0001193125-21-326065.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-21-326065 |
| 2021-11-03 | 16:01 ET | [8-K](/filings/0001193125-21-318383.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-318383 |
| 2021-10-29 | 18:30 ET | [S-1/A](/filings/0001193125-21-311645.md) | Registration statement, amended | 0001193125-21-311645 |
| 2021-10-27 | 21:21 ET | [S-1/A](/filings/0001193125-21-308383.md) | Registration statement, amended | 0001193125-21-308383 |
| 2021-10-20 | 06:09 ET | [S-1/A](/filings/0001193125-21-302493.md) | Registration statement, amended | 0001193125-21-302493 |
| 2021-10-08 | 17:09 ET | [S-1/A](/filings/0001193125-21-295616.md) | Registration statement, amended | 0001193125-21-295616 |
| 2021-10-01 | 16:52 ET | [S-1](/filings/0001193125-21-289805.md) | Registration statement | 0001193125-21-289805 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.